KYNU

protein-coding

kynureninase

Gene summary

Kynureninase is a pyridoxal-5'-phosphate (pyridoxal-P) dependent enzyme that catalyzes the cleavage of L-kynurenine and L-3-hydroxykynurenine into anthranilic and 3-hydroxyanthranilic acids, respectively. Kynureninase is involved in the biosynthesis of NAD cofactors from tryptophan through the kynurenine pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2010]

MANE transcript

NM_003937.3

Inheritance

AR

ClinVar variants

P:28U:79B:18

Top phenotype

Vertebral, cardiac, renal, and limb defects syndrome 2

gnomAD constraint

pLI —, LoF o/e 0.98

Max pathogenic AF

—

Genomic locus

chr2:142,877,657-143,055,833

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~178.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

vertebral, cardiac, renal, and limb defects syndrome 2STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0060555

Submitter: PanelApp Australia

vertebral, cardiac, renal, and limb defects syndrome 2STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0060555

Submitter: Labcorp Genetics (formerly Invitae)

encephalopathy due to hydroxykynureninuriaLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0009372

Submitter: Ambry Genetics

encephalopathy due to hydroxykynureninuriaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009372

Submitter: PanelApp Australia

encephalopathy due to hydroxykynureninuriaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009372

Submitter: Labcorp Genetics (formerly Invitae)

vertebral, cardiac, renal, and limb defects syndrome 2LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0060555

Submitter: Laboratory for Molecular Medicine

This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.

congenital vertebral-cardiac-renal anomalies syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0020831

Submitter: Orphanet

encephalopathy due to hydroxykynureninuriaSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009372

Submitter: Orphanet

vertebral, cardiac, renal, and limb defects syndrome 2DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0060555

Submitter: ClinGen

*KYNU* was first reported in relation to autosomal recessive vertebral, cardiac, renal, and limb defects syndrome 2 in 2017 (Shi H, et al., 2017, PMID: 28792876) but was previously identified with hydroxykynureninuria in 2007 (Christensen M, et al., 2007, PMID: 17334708). Congenital defects found in VCRL2 include segmentation defects, cardiac defects such as hypoplastic heart, hypoplastic kidneys, missing kidneys, clinodactyly, radial deviation, and polydactyly. Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least 14 unique variants (e.g. missense, nonsense, frameshift, splicing, and large deletion) have been reported in 11 probands from 5 publications (PMIDs: 28792876, 33942433, 31923704, 17334708, 34200361). Variants in this gene segregated with disease in 1 additional family member. The gene *KYNU* encodes Kynureninase, one of the enzymes responsible for the biosynthesis of NAD from Trpytophan. This gene-disease association is further supported by its biochemical function in the kynurenine pathway (PMID: 8706755) and a knockout mouse model (PMID: 28792876) which recapitulates the phenotype on a NAD-restricted diet. In summary, *KYNU* is definitively associated with autosomal recessive vertebral, cardiac, renal, and limb defects syndrome 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the Aminoacidopathy GCEP on 07/10/2020. It was reevaluated on 08/01/2022. As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of 5 new cases (PMIDs: 33942433 and 34200361).

Clinical Genomic Database (CGD)

Vertebral, cardiac, renal, and limb defects syndrome 2AR

Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Renal

Intervention: Cardiovascular

Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early identifcation and management

Refs: 17334708; 28792876; 34200361Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to KYNU variants in ClinVar

9 Conditions Cataloged
not specifiedTotal: 84
not providedTotal: 31
Vertebral, cardiac, renal, and limb defects syndrome 2Total: 25
KYNU-related disorderTotal: 19
HydroxykynureninuriaTotal: 11
Congenital NAD deficiency disorderTotal: 9
Catel-Manzke syndromeTotal: 3
Paediatric disordersTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_003937.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
9
clinvar
3
clinvar
13
missense
3
clinvar
6
clinvar
72
clinvar
5
clinvar
1
clinvar
87
nonsense
1
clinvar
5
clinvar
1
clinvar
7
start loss
0
frameshift
7
clinvar
7
splice donor/acceptor (+/-2bp)
2
clinvar
4
clinvar
5
clinvar
11
Total62279144125

Highest pathogenic variant AF is 0.00015750766

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 61 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_003937.3RefSeqNP_003928.113MANE Select
ENST00000264170.9EnsemblENSP00000264170.413MANE Select
NM_001032998.2RefSeqNP_001028170.110Standard
NM_001199241.2RefSeqNP_001186170.113Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Tryptophan metabolism - Homo sapiens (human)
  • Tryptophan Metabolism
  • Selenium Micronutrient Network
  • NAD Biosynthesis II (from tryptophan)
  • Tryptophan metabolism

Biological Process

  • tryptophan catabolic process
  • aging
  • NAD biosynthetic process
  • tryptophan catabolic process to kynurenine
  • tryptophan catabolic process to acetyl-CoA

Molecular Function

  • pyridoxal phosphate binding
  • kynureninase activity
  • protein homodimerization activity
  • 3-hydroxykynureninase activity

Cellular Component

  • nucleoplasm
  • mitochondrion
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000264170
Coding exons
13
Length
164824
Individuals with no LoFs
125573
Homozygous LoFs
0
Heterozygous LoFs
175
Defined
125748
p
0.000696
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.4132672491.070.00001263032
Missense (PolyPhen)9395.6410.972391068
Synonymous0.8297988.90.8880.00000456878
Loss of Function0.09022727.50.9810.00000151333

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000940.00092rare
Latino/Admixed American0.000220.00020rare
Ashkenazi Jewish0.000330.00030rare
East Asian0.000650.00065rare
Finnish0.000380.00037rare
European (Non-Finnish)0.00100.00098notable
South Asian0.000500.00046rare
Other0.000860.00081rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity. {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:28792876, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.;
Disease
DISEASE: Hydroxykynureninuria (HYXKY) [MIM:236800]: An inborn error of amino acid metabolism characterized by massive urinary excretion of large amounts of kynurenine, 3-hydroxykynurenine and xanthurenic acid. Affected individuals manifest renal tubular dysfunction, metabolic acidosis, psychomotor retardation, non- progressive encephalopathy, and muscular hypertonia. {ECO:0000269|PubMed:17334708, ECO:0000269|PubMed:28792876}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vertebral, cardiac, renal, and limb defects syndrome 2 (VCRL2) [MIM:617661]: An autosomal recessive congenital malformation syndrome characterized by vertebral segmentation abnormalities, congenital cardiac defects, renal defects, and distal mild limb defects. {ECO:0000269|PubMed:28792876}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.105

Intolerance Scores

LoFtool
0.539
RVIS EVS
-0.6
RVIS percentile EVS
18.06

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.876

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.